comparemela.com

Latest Breaking News On - Specific gene editing system - Page 1 : comparemela.com

Poseida Therapeutics Announces Virtual 2024 Annual Meeting Of Stockholders

SAN DIEGO, June 3, 2024 /PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX ), a clinical-stage allogeneic cell therapy and genetic medi

Poseida-therapeutics-inc
Linkedin
Nasdaq
Annual-meeting
Poseida-therapeutics
Specific-gene-editing-system
Booster-molecule

Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition

SAN DIEGO - Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the acceptance.

United-states
San-diego-convention-center
California
San-diego
American
Sarah-thailing
Alex-lobo
Nasdaq
Details-for-the-company
American-society-of-hematology
Poseida-therapeutics-inc
Annual-meeting

Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences

/PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform.

Piper-sandler
Linkedin
Twitter
Poseida-therapeutics-inc
Nasdaq
Prnewswire-poseida-therapeutics-inc
Annual-virtual-healthcare
Media-section
Poseida-therapeutics
Specific-gene-editing-system
Nc

Poseida Therapeutics Announces Leadership Appointments

/PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform.

University-of-pennsylvania
Pennsylvania
United-states
Mark-gergen
Johanna-mylet
Neurocrine-biosciences
Eric-ostertag
Devon-shedlock
Lisa-portale
Kristin-martin
Linkedin
Twitter

Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting

/PRNewswire/ Poseida Therapeutics, Inc. (Nadsaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform.

Washington
District-of-columbia
United-states
Hubert-tseng
Yan-zhang
Exchange-commission
Linkedin
Society-for-immunotherapy-of-cancer
Twitter
Drug-administration
Poseida-therapeutics-inc
Prnewswire-poseida-therapeutics-inc

vimarsana © 2020. All Rights Reserved.